A Phase 3 Study to Evaluate the Efficacy and Safety of K-877 in Chinese Patients With High TG and Low HDL-C

PHASE3CompletedINTERVENTIONAL
Enrollment

353

Participants

Timeline

Start Date

September 17, 2021

Primary Completion Date

February 2, 2023

Study Completion Date

February 2, 2023

Conditions
Hyperlipidemia
Interventions
DRUG

K-877 0.1 mg tablet

K-877 0.1 mg tablet x 2 twice daily

DRUG

Fenofibrate 200 mg capsule

Fenofibrate 200 mg capsule once daily

DRUG

Placebo tablet

Placebo tablet x 2 twice daily

DRUG

Placebo capsule

Placebo capsule once daily

DRUG

K-877 0.1 mg tablet

K-877 0.1 mg tablet twice daily

DRUG

Placebo tablet

Placebo tablet twice daily

Trial Locations (33)

100029

Beijing Anzhen Hospital, Capital Medical University, Beijing

100032

Peking Union Medical College Hospital, Guangdong

100730

Beijing Hospital, Beijing

Beijing Tongren Hospital, Capital Medical University, Beijing

101200

Beijing Pinggu Hospital, Beijing

150001

The First Affiliated Hospital of Harbin Medical University, Helongjiang

200336

Shanghai Tongren Hospital, Shanghai

211100

Nanjing Jiangning Hospital, Jiangsu

Sir Run Run Hospital Nanjing Medical Universtiy, Jiangsu

212001

Affiliated Hospital of Jiangsu University, Jiangsu

232000

Huainan First People's Hospital, Anhui

300121

Tianjin Union Medical Center, Tianjin

310015

The Affiliated Hospital of Hangzhou Normal University, Zhejiang

325000

People's Hospital of Wenzhou City, Zhejiang

330006

Jiangxi Provincial People's Hospital, Jiangxi

The First Affiliated Hospital of Nanchang University, Jiangxi

China-Japan Union Hospital of Jilin University, Jilin

330008

The First Hospital of Nanchang, Jiangxi

332000

Jiu Jiang No. 1 People's Hospital, Jiangxi

337055

Pingxiang People's Hospital, Jiangxi

350005

The First Affiliated Hospital of Fujian Medical University, Fujian

410013

The Third Xiangya Hospital of Central South University, Hunan

410015

The Third Hospital of Changsha, Hunan

430022

Union Hospital, Tongji Medical College of Huazhong University of Science & Technology, Hubei

430030

Tongji Hospital, Tongji Medical College of HUST, Hubei

510080

The First Affiliated Hospital, Sun Yat-sen University, Guangdong

510120

Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangdong

530021

The People's Hospital of Guangxi Zhuang Autonomous Region, Guangxi

570311

Hainan General Hospital, Hainan

610066

Chengdu Xinhua Hospital, Chengdu

618000

People's Hospital of Deyang City, Sichuan

710068

Shaanxi Provincial People's Hospital, Hubei

050000

The Second Hospital of Hebei Medical University, Hebei

All Listed Sponsors
lead

Kowa Company, Ltd.

INDUSTRY

NCT04998981 - A Phase 3 Study to Evaluate the Efficacy and Safety of K-877 in Chinese Patients With High TG and Low HDL-C | Biotech Hunter | Biotech Hunter